(2E)-3-(2,4-dichlorophenyl)-1-(2,4-dimethylphenyl)prop-2-en-1-one, 95.0%, 10g

Ethyl 5-phenylthiazole-2-carboxylate, 95.0%, 5g

Methyl 2-amino-5-fluoro-3-nitrobenzoate, 95.0%, 500mg

1H,4H,7H-pyrazolo[4,3-d]pyrimidin-7-one, 98%, 100mg

2-Acetoxyisobutyryl Chloride>97.0%(T)25g

Oxalic acid solution, ROTI®Volum 0.05 mol/l - 0.1 N, ampoule, 1 piece, plastic packaging.

4-(5-Methyl-[1,2,4]oxadiazol-3-yl)-benzoic acid methyl ester, 95.0%, 5g

3,4-Dihydro-2h-1,4-benzothiazine-1,1-dione, 97%, 2.5g

Pentafluorophenyltrimethoxysilane, >95%, 25g

4-Chloro-2-methylsulfanyl-pyrazolo[1,5-a][1,3,5]triazine, 95.0%, 5g

(2S,4R)-4-(3-Bromobenzyl)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95.0%, 250mg

H-Phe-NH2 HCl, 95%, 100g

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 95.0%, 5g